Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States

Clinical features and management of human monkeypox: a retrospective observational study in the UK

(2022) Hugh Adler et al.   LANCET INFECTIOUS DISEASES

Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021

(2022) Agam K. Rao et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus

(2022) Joana Isidro et al.   NATURE MEDICINE

Monkeypox Outbreak — Nine States, May 2022

(2022) Faisal S. Minhaj et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Clinical course and outcome of human monkeypox in Nigeria

(2020) Dimie Ogoina et al.   CLINICAL INFECTIOUS DISEASES

Human Monkeypox

(2019) Eskild Petersen et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox

(2019) Michael Merchlinsky et al.   ANTIVIRAL RESEARCH

A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy

(2019) Ellen M. Beer et al.   PLoS Neglected Tropical Diseases

Oral Tecovirimat for the Treatment of Smallpox

(2018) Douglas W. Grosenbach et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

(2014) Diana F Florescu et al.   Expert Review of Anti-Infective Therapy

Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus

(2011) S. K. Smith et al.   JOURNAL OF VIROLOGY